Overview Safety and Tolerability of Metronidazole Gel 1.3% Status: Completed Trial end date: 2016-11-30 Target enrollment: Participant gender: Summary Multicenter, open-label study to evaluate safety and tolerability of Metronidazole Vaginal Gel in females 12 to <18 years for the treatment of bacterial vaginosis. Phase: Phase 4 Details Lead Sponsor: Insud PharmaWatson PharmaceuticalsCollaborator: Allergan Sales, LLCTreatments: Metronidazole